Renishaw (OTCMKTS:RNSHF) was upgraded by research analysts at The Goldman Sachs Group from a “buy” rating to a “conviction-buy” rating in a note issued to investors on Thursday, The Fly reports.
RNSHF has been the subject of several other reports. Zacks Investment Research lowered Renishaw from a “buy” rating to a “hold” rating in a research note on Wednesday, December 29th. Stifel Nicolaus upgraded Renishaw from a “hold” rating to a “buy” rating in a research report on Tuesday, October 26th. Morgan Stanley lowered Renishaw from an “equal weight” rating to a “sell” rating and set a $4,399.00 price objective for the company. in a research note on Thursday, November 25th. Finally, Barclays reissued a “sell” rating and issued a $4,695.00 price target on shares of Renishaw in a report on Monday, October 25th. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating, two have given a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $3,060.67.
OTCMKTS:RNSHF opened at $76.88 on Thursday. Renishaw has a one year low of $63.19 and a one year high of $97.00. The business has a fifty day moving average price of $76.65 and a 200-day moving average price of $73.44.
Renishaw Plc engages in the design, manufacture, and marketing of metrology and healthcare products. It operates through the Metrology and Healthcare segments. The Metrology segment engages in the fields of industrial automation and motion systems. The Healthcare segment offers engineering solutions for stereotactic neurosurgery, analytical systems that identify and assess biochemical changes associated with disease formation and progression, the supply of specially configured metal additive manufacturing (AM) systems for medical and dental applications, the supply of implants to hospitals and specialist design centres for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture high-quality dental restorations.
Featured Story: Why do earnings reports matter?
Receive News & Ratings for Renishaw Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renishaw and related companies with MarketBeat.com's FREE daily email newsletter.